Cargando…

A Chinese patient with POLR3A-related leukodystrophy: a case report and literature review

BACKGROUND: Leukodystrophies are hereditary white matter diseases characterized by genetic polymorphisms and considerable phenotypic variability. They can be classified into myelin and non-myelin malformations. These diseases are rare, affecting 1 out of 250,000–500,000 individuals and can manifest...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Lei, Lin, Weihong, Meng, Hongmei, Zhang, Wuqiong, Hou, Shuai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641775/
https://www.ncbi.nlm.nih.gov/pubmed/37965164
http://dx.doi.org/10.3389/fneur.2023.1269237
_version_ 1785146827914346496
author Sun, Lei
Lin, Weihong
Meng, Hongmei
Zhang, Wuqiong
Hou, Shuai
author_facet Sun, Lei
Lin, Weihong
Meng, Hongmei
Zhang, Wuqiong
Hou, Shuai
author_sort Sun, Lei
collection PubMed
description BACKGROUND: Leukodystrophies are hereditary white matter diseases characterized by genetic polymorphisms and considerable phenotypic variability. They can be classified into myelin and non-myelin malformations. These diseases are rare, affecting 1 out of 250,000–500,000 individuals and can manifest at any age. A subtype of leukodystrophy, associated with missense mutations in the RNA polymerase subunit III (POLR3A) gene, is inherited in an autosomal recessive manner. CASE REPORT: We report and analyse a case of a 34-year-old female who presented with ataxia. Magnetic Resonance Imaging (MRI) of the brain revealed demyelinating lesions in the white matter. Genetic testing identified the c.4044C > G and c.1186-2A > G variants in the POLR3A gene. The patient was diagnosed with hypomyelinating leukodystrophy type 7 and received neurotrophic and symptomatic supportive therapy. However, after 1 month of follow-up, there was no improvement in her symptoms. CONCLUSION: POLR3A-induced leukodystrophy is relatively rare and not well understood, making it challenging to diagnose and easy to overlook. The prognosis for this disease is generally poor, significantly impacting the quality of life of affected individuals. Currently, no cure is available for this condition, and treatment is limited to managing symptoms. Further research into new treatment methods for POLR3A-induced leukodystrophy is imperative to improve the quality of life and potentially extend the life expectancy of patients.
format Online
Article
Text
id pubmed-10641775
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106417752023-11-14 A Chinese patient with POLR3A-related leukodystrophy: a case report and literature review Sun, Lei Lin, Weihong Meng, Hongmei Zhang, Wuqiong Hou, Shuai Front Neurol Neurology BACKGROUND: Leukodystrophies are hereditary white matter diseases characterized by genetic polymorphisms and considerable phenotypic variability. They can be classified into myelin and non-myelin malformations. These diseases are rare, affecting 1 out of 250,000–500,000 individuals and can manifest at any age. A subtype of leukodystrophy, associated with missense mutations in the RNA polymerase subunit III (POLR3A) gene, is inherited in an autosomal recessive manner. CASE REPORT: We report and analyse a case of a 34-year-old female who presented with ataxia. Magnetic Resonance Imaging (MRI) of the brain revealed demyelinating lesions in the white matter. Genetic testing identified the c.4044C > G and c.1186-2A > G variants in the POLR3A gene. The patient was diagnosed with hypomyelinating leukodystrophy type 7 and received neurotrophic and symptomatic supportive therapy. However, after 1 month of follow-up, there was no improvement in her symptoms. CONCLUSION: POLR3A-induced leukodystrophy is relatively rare and not well understood, making it challenging to diagnose and easy to overlook. The prognosis for this disease is generally poor, significantly impacting the quality of life of affected individuals. Currently, no cure is available for this condition, and treatment is limited to managing symptoms. Further research into new treatment methods for POLR3A-induced leukodystrophy is imperative to improve the quality of life and potentially extend the life expectancy of patients. Frontiers Media S.A. 2023-10-27 /pmc/articles/PMC10641775/ /pubmed/37965164 http://dx.doi.org/10.3389/fneur.2023.1269237 Text en Copyright © 2023 Sun, Lin, Meng, Zhang and Hou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Sun, Lei
Lin, Weihong
Meng, Hongmei
Zhang, Wuqiong
Hou, Shuai
A Chinese patient with POLR3A-related leukodystrophy: a case report and literature review
title A Chinese patient with POLR3A-related leukodystrophy: a case report and literature review
title_full A Chinese patient with POLR3A-related leukodystrophy: a case report and literature review
title_fullStr A Chinese patient with POLR3A-related leukodystrophy: a case report and literature review
title_full_unstemmed A Chinese patient with POLR3A-related leukodystrophy: a case report and literature review
title_short A Chinese patient with POLR3A-related leukodystrophy: a case report and literature review
title_sort chinese patient with polr3a-related leukodystrophy: a case report and literature review
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641775/
https://www.ncbi.nlm.nih.gov/pubmed/37965164
http://dx.doi.org/10.3389/fneur.2023.1269237
work_keys_str_mv AT sunlei achinesepatientwithpolr3arelatedleukodystrophyacasereportandliteraturereview
AT linweihong achinesepatientwithpolr3arelatedleukodystrophyacasereportandliteraturereview
AT menghongmei achinesepatientwithpolr3arelatedleukodystrophyacasereportandliteraturereview
AT zhangwuqiong achinesepatientwithpolr3arelatedleukodystrophyacasereportandliteraturereview
AT houshuai achinesepatientwithpolr3arelatedleukodystrophyacasereportandliteraturereview
AT sunlei chinesepatientwithpolr3arelatedleukodystrophyacasereportandliteraturereview
AT linweihong chinesepatientwithpolr3arelatedleukodystrophyacasereportandliteraturereview
AT menghongmei chinesepatientwithpolr3arelatedleukodystrophyacasereportandliteraturereview
AT zhangwuqiong chinesepatientwithpolr3arelatedleukodystrophyacasereportandliteraturereview
AT houshuai chinesepatientwithpolr3arelatedleukodystrophyacasereportandliteraturereview